Unlocking the potential of biomedical innovation with Human Organ Trials

Instead of putting patient lives at risk testing unproven technologies in First-in-Human Clinical Trials

We bring donated organs back to life with organ perfusion technology to run First-in-Human Organ Trials

“Revalia Bio are giving our families the chance to create a lasting legacy through donation – and I am so grateful to be able to offer this to families, who would otherwise be excluded.”

Bradon Nave, Director of Innovations at LifeShare

We are redefining biomedical innovation:

No risk to patients By testing directly on donated human organs

‘Impossible’ research ​That could never be done in living patients

Accelerated innovation From 10+ years to <1 month for first human results